Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments
Go back to Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments| (NASDAQ: MNPR) | Delayed: 113.49 +3.53 (3.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.96 | 52 Week High | $ | |||
| Open | $113.84 | 52 Week Low | $ | |||
| Day High | $113.84 | P/E | N/A | |||
| Day Low | $113.26 | EPS | $ | |||
| Volume | 3,416 | |||||

